Drug details

Venbysi XR (venlafaxine extended-release tablets)

type of Antidepressants, SNRIs

Venbysi XR (venlafaxine extended-release tablets) is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated in adults for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).

This drug may have the following side effects:

• nausea,
• loss of appetite,
• constipation,
• dry mouth,
• sweating,
• drowsiness,
• impotence, and
• abnormal ejaculation,
• decreased libido.

The following drugs are related to Venbysi XR, either as a replacement or used together:

• Xanax (alprazolam)
• Ativan (lorazepam)
• Ativan Injection (lorazepam injection)
• Wellbutrin (bupropion hcl)
• Wellbutrin XL (bupropion hydrochloride extended-release)
• Wellbutrin SR (bupropion hydrochloride sustained-release)
• Buspar (buspirone)
• Celexa (citalopram hydrobromide)
• Cymbalta (duloxetine hcl)
• Effexor (venlafaxine hydrochloride)
• Effexor XR (venlafaxine hydrochloride extended-release)
• Lexapro (escitalopram oxalate)
• Zoloft (sertraline hcl)
• Viibryd (vilazodone hydrochloride)